The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | The importance of genomic testing in MPNs
Jean-Jacques Kiladjian, MD, PhD, Saint-Louis Hospital & Paris Diderot University, Paris, France, briefly discusses the importance of genomic testing in myeloproliferative neoplasms (MPNs), highlighting the benefit of using next-generation sequencing (NGS) methods where possible, and the value of using genomic information to guide treatment decisions. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
Disclosures
Advisory boards for Novartis, Abbvie, BMS, AOP Orphan.
